Tomoyuki Endo

4.6k total citations
147 papers, 2.6k citations indexed

About

Tomoyuki Endo is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Tomoyuki Endo has authored 147 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 32 papers in Oncology and 28 papers in Epidemiology. Recurrent topics in Tomoyuki Endo's work include Hematopoietic Stem Cell Transplantation (27 papers), Lymphoma Diagnosis and Treatment (15 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Tomoyuki Endo is often cited by papers focused on Hematopoietic Stem Cell Transplantation (27 papers), Lymphoma Diagnosis and Treatment (15 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Tomoyuki Endo collaborates with scholars based in Japan, United States and Germany. Tomoyuki Endo's co-authors include Mitsufumi Nishio, Thomas J. Kipps, Desheng Lu, Dennis A. Carson, Katsuya Fujimoto, Tetsuya Fukuda, Ingo G.H. Schmidt‐Wolf, John C. Reed, Junko Ohata and Nathan J. Zvaifler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tomoyuki Endo

132 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoyuki Endo Japan 26 691 641 626 548 519 147 2.6k
Don L. Siegel United States 34 607 0.9× 1.0k 1.6× 492 0.8× 742 1.4× 904 1.7× 107 3.4k
Yoo Hong Min South Korea 32 401 0.6× 1.5k 2.3× 604 1.0× 737 1.3× 1.2k 2.3× 204 3.6k
Uwe Hillen Germany 34 690 1.0× 816 1.3× 285 0.5× 1.0k 1.9× 179 0.3× 136 3.8k
Junichi Tsukada Japan 31 755 1.1× 713 1.1× 276 0.4× 434 0.8× 513 1.0× 187 3.0k
Hiroyuki Tagawa Japan 31 690 1.0× 1.9k 2.9× 445 0.7× 834 1.5× 331 0.6× 120 3.8k
Joo Seop Chung South Korea 23 394 0.6× 296 0.5× 247 0.4× 515 0.9× 415 0.8× 101 1.8k
Lee Js Taiwan 27 305 0.4× 982 1.5× 262 0.4× 419 0.8× 388 0.7× 164 3.1k
Everardo Cobos United States 28 787 1.1× 1.1k 1.7× 166 0.3× 739 1.3× 409 0.8× 159 2.5k
John R. Krause United States 25 250 0.4× 319 0.5× 473 0.8× 667 1.2× 708 1.4× 127 2.4k
Bor‐Sheng Ko Taiwan 32 259 0.4× 1.7k 2.7× 910 1.5× 435 0.8× 1.3k 2.5× 141 3.8k

Countries citing papers authored by Tomoyuki Endo

Since Specialization
Citations

This map shows the geographic impact of Tomoyuki Endo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Endo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Endo more than expected).

Fields of papers citing papers by Tomoyuki Endo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyuki Endo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Endo. The network helps show where Tomoyuki Endo may publish in the future.

Co-authorship network of co-authors of Tomoyuki Endo

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Endo. A scholar is included among the top collaborators of Tomoyuki Endo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Endo. Tomoyuki Endo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Matsumura, Nobutoshi, et al.. (2024). Serotonin Syndrome Induced by Fentanyl Alone in an Adult Patient After Cardiac Surgery: A Case Report. Cureus. 16(7). e64832–e64832. 2 indexed citations
4.
Chiba, Masahiro, Takashi Ishio, Michiyuki Maeda, et al.. (2024). Genome-wide CRISPR screen identifies MAD2L1BP and ANAPC15 as targets for brentuximab vedotin sensitivity in CD30+ peripheral T-cell lymphoma. Leukemia. 39(1). 243–247. 1 indexed citations
5.
Hirano, Masamitsu, et al.. (2024). Anti-N-Methyl-D-Aspartate Receptor (Anti-NMDAR) Encephalitis in Small Cell Lung Cancer: A Case Report. Cureus. 16(11). e73713–e73713.
6.
Abe, Yoshinobu, et al.. (2023). Overwhelming Post-splenectomy Infection Caused by Escherichia coli 20 Years After Splenectomy: A Case Report. Cureus. 15(7). e42184–e42184. 1 indexed citations
7.
Chiba, Masahiro, Joji Shimono, Takashi Ishio, et al.. (2023). Whole-genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in adult T-cell leukemia/lymphoma. Blood. 143(14). 1379–1390. 8 indexed citations
8.
Senjo, Hajime, Shimpei I. Kubota, Yuki Tanaka, et al.. (2023). Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT. Blood. 142(5). 477–492. 16 indexed citations
9.
Ishii, Takuro, et al.. (2023). Ultrasound vector flow imaging during veno-arterial extracorporeal membrane oxygenation in a thoracic aorta model. Journal of Artificial Organs. 27(3). 230–237. 5 indexed citations
10.
Ara, Takahide, Yuta Hasegawa, Hiroyuki Ohigashi, et al.. (2023). Low-Dose ATG Has the Same Risk of CMV Reactivation after Allogeneic PBSCT As Ptcy, but Letemovir Is Effective in Preventing CMV Reactivation. Blood. 142(Supplement 1). 3546–3546. 1 indexed citations
11.
Abe, Yoshinobu, et al.. (2023). Massive Gastric Dilatation and Multi-Organ Ischemia Due to Superior Mesenteric Artery Syndrome: A Rare Case Report. American Journal of Case Reports. 24. e940910–e940910.
12.
Ara, Takahide, Toshihiro Matsukawa, Souichi Shiratori, et al.. (2023). PB2581: BACILLUS BACTEREMIA IS DETECTED EARLIER THAN OTHER GRAM-POSITIVE RODS IN BLOOD CULTURES OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES.. HemaSphere. 7(S3). e65304ae–e65304ae.
13.
Sekiguchi, Naohiro, Shinya Rai, Wataru Munakata, et al.. (2022). Two‐year outcomes of tirabrutinib monotherapy in Waldenström’s macroglobulinemia. Cancer Science. 113(6). 2085–2096. 22 indexed citations
14.
Sekiguchi, Naohiro, Shinya Rai, Wataru Munakata, et al.. (2020). A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström’s macroglobulinemia. Cancer Science. 111(9). 3327–3337. 60 indexed citations
15.
Imadome, Ken‐Ichi, Tohru Kobayashi, Masahide Yamamoto, et al.. (2020). Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Advances. 4(13). 2918–2926. 53 indexed citations
16.
Ishio, Takashi, Junichi Sugita, Eiko Hayase, et al.. (2018). Hematogones Predict Better Outcome in Allogeneic Hematopoietic Stem Cell Transplantation Irrespective of Graft Sources. Biology of Blood and Marrow Transplantation. 24(10). 1990–1996. 10 indexed citations
17.
Takahata, Mutsumi, Satoshi Hashino, Katsuya Fujimoto, et al.. (2012). [Clinical efficacy of high-dose cepharanthine for idiopathic thrombocytopenic purpura: retrospective multicenter analysis].. PubMed. 53(12). 1983–90. 4 indexed citations
18.
Hori, Masahiro, Tetsuro Shinada, Norio Shimamoto, et al.. (2009). Performance enhancement of semiconductor devices by control of discrete dopant distribution. Nanotechnology. 20(36). 365205–365205. 9 indexed citations
20.
Nomura, Toshifumi, et al.. (2004). Plasma exchange; a promising treatment for toxic epidermal necrolysis with AIDS.. PubMed. 18(18). 2446–8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026